135 related articles for article (PubMed ID: 32930885)
1. Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution.
Wang Y; Wu J; Li W; Li J; Liu R; Yang B; Li C; Jiang T
Childs Nerv Syst; 2021 Feb; 37(2):411-417. PubMed ID: 32930885
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
[TBL] [Abstract][Full Text] [Related]
3. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
[TBL] [Abstract][Full Text] [Related]
4. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
[TBL] [Abstract][Full Text] [Related]
5. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
[TBL] [Abstract][Full Text] [Related]
6. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
[TBL] [Abstract][Full Text] [Related]
8. SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.
Mangum R; Varga E; Boué DR; Capper D; Benesch M; Leonard J; Osorio DS; Pierson CR; Zumberge N; Sahm F; Schrimpf D; Pfister SM; Finlay JL
Childs Nerv Syst; 2016 Dec; 32(12):2439-2446. PubMed ID: 27444290
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S
Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294
[TBL] [Abstract][Full Text] [Related]
10. Retrospective family study of childhood medulloblastoma.
Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM
Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260
[TBL] [Abstract][Full Text] [Related]
11. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
[TBL] [Abstract][Full Text] [Related]
12. First evidence of genotype-phenotype correlations in Gorlin syndrome.
Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT
J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197
[TBL] [Abstract][Full Text] [Related]
13. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.
Brugières L; Remenieras A; Pierron G; Varlet P; Forget S; Byrde V; Bombled J; Puget S; Caron O; Dufour C; Delattre O; Bressac-de Paillerets B; Grill J
J Clin Oncol; 2012 Jun; 30(17):2087-93. PubMed ID: 22508808
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031
[TBL] [Abstract][Full Text] [Related]
15. Concurrent medulloblastoma and cardiac fibroma: a rare presentation of Gorlin-Goltz syndrome.
Alanazi R; Alkhaibary A; Alfaqawwy W; AlSufiani F; Ahmad N; Aljared T
Childs Nerv Syst; 2023 Sep; 39(9):2499-2504. PubMed ID: 37160435
[TBL] [Abstract][Full Text] [Related]
16. Congenital medulloblastoma in two brothers with SUFU-mutated Gorlin-Goltz syndrome: Case reports and literature review.
Chen Y; Zhang H; Zhao Y; Ma J
Front Oncol; 2022; 12():988798. PubMed ID: 36313636
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
18. Mutations in SUFU predispose to medulloblastoma.
Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
[TBL] [Abstract][Full Text] [Related]
19. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
[TBL] [Abstract][Full Text] [Related]
20. Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort.
Kloth K; Obrecht D; Sturm D; Pietsch T; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S
Front Oncol; 2021; 11():756025. PubMed ID: 34888241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
